Predictors of death and reinfarction at 30 days after primary angioplasty: The GUSTO Ilb and RAPPORT trials
- 31 March 2000
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 139 (3) , 476-481
- https://doi.org/10.1016/s0002-8703(00)90091-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial InfarctionCirculation, 1998
- Comparison of Primary Coronary Angioplasty and Intravenous Thrombolytic Therapy for Acute Myocardial InfarctionJAMA, 1997
- A Clinical Trial Comparing Primary Coronary Angioplasty with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1997
- A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial InfarctionNew England Journal of Medicine, 1996
- Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hourThe Lancet, 1996
- Time from symptom onset to treatment and outcomes after thrombolytic therapyJournal of the American College of Cardiology, 1996
- Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insightsJournal of the American College of Cardiology, 1995
- Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial InfarctionCirculation, 1995
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsPublished by Elsevier ,1994
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993